The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 05, 2019
Filed:
Oct. 13, 2015
Applicant:
Toray Industries, Inc., Tokyo, JP;
Inventors:
Akira Kurihara, Kamakura, JP;
Fumiyoshi Okano, Kamakura, JP;
Assignee:
TORAY INDUSTRIES, INC., Tokyo, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 14/47 (2006.01); A61K 45/06 (2006.01); A61K 31/7088 (2006.01); A61K 38/00 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01); A61K 38/17 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 31/7088 (2013.01); A61K 38/1709 (2013.01); A61K 38/20 (2013.01); A61K 38/208 (2013.01); A61K 38/21 (2013.01); A61K 38/212 (2013.01); A61K 38/215 (2013.01); A61K 38/217 (2013.01); A61K 45/06 (2013.01); C07K 14/47 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/53 (2013.01);
Abstract
Provided is a method for inducing immunity for therapy of a cancer(s). The method includes the step of administering to an individual with cancer at least one polypeptide selected from the polypeptides (a) or (b) below, and/or a recombinant vector(s) that comprise(s) a polynucleotide(s) encoding the at least one polypeptide, the recombinant vector(s) being capable of expressing the polypeptide(s) in vivo: (a) a polypeptide in any one of the amino acid sequences of SEQ ID NOs: 2, 4, 8, 10 and 12; and (b) a polypeptide having a sequence identity of not less than 95% to the polypeptide (a).